SAN DIEGO, Nov. 10, 2025 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced its financial results for the third […]
SAN DIEGO, Nov. 10, 2025 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye” or the “Company”), a clinical stage biotechnology company developing next-generation molecules that modulate G-protein-coupled receptors to treat obesity, overweight, and related […]
SAN DIEGO, Nov. 10, 2025 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that its Phase 2 study evaluating the efficacy, safety and tolerability of investigational compound NBI-1070770 in adults with major depressive disorder […]
Following global commercial launch in September, Illumina Protein Prep’s “out of the box” solution drives extraordinary accessibility to proteomics for researchers, with over 40,000 samples processed Sydney Mass Spectrometry is the first facility in the […]
UC San Diego researchers developed a machine learning model that accurately predicts skin cancer risk across ancestries, improving equity in early detection and outcomes using genetics, lifestyle, and social factors. Click here to view original […]
SAN DIEGO, Nov. 10, 2025 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that investigational rosnilimab was safe and well tolerated but did not […]
Engineers have developed a battery-free electronic sticker that attaches to everyday objects like a drinking cup and monitors vitamin C levels from a person’s fingertip sweat. The technology could make personal nutrition monitoring as effortless […]
SAN DIEGO, Nov. 10, 2025 (GLOBE NEWSWIRE) — Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of systemically delivered, targeted genetic medicines, presented new data on […]
SAN DIEGO, Nov. 10, 2025 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced […]
SAN DIEGO–(BUSINESS WIRE)–Iambic, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, today announced raising over $100 million in an oversubscribed financing round with balanced support from […]
SAN DIEGO–(BUSINESS WIRE)–Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conference during the month of November. […]
Researchers Using a ‘Top-Down’ Approach Analyze Dr Joe Dispenza’s Seven-Day Intensive Meditation Retreat, Revealing the Human Mind’s Power to Reprogram the Body at a Cellular Level. SAN DIEGO, Nov. 10, 2025 /PRNewswire/ — Dr Joe […]
Iambic Therapeutics has raised more than $100 million in a new funding round, CEO Tom Miller exclusively told Endpoints News, and the San Diego biotech plans on using the cash to advance multiple drugs in […]
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Greetings from sunny San Diego! This is Jonathan Wosen, West Coast biotech & life sciences reporter, filling […]
Maximize capping efficiency and minimize double-stranded RNA (“dsRNA”) in the manufacturing of self-amplifying mRNA SAN DIEGO, Nov. 10, 2025 /PRNewswire/ — Primrose Bio, Inc. (“Primrose”), a company with proprietary therapeutic manufacturing technologies, today announced the […]
SAN DIEGO–(BUSINESS WIRE)– #ELANE–Onchilles Pharma Publishes Landmark ELANE Pathway Study and Advances N17350 Toward the Clinic With New Financing and Leading Clinical Advisor Click here to view original post Click Here to Publish/Feature Your Company […]
Intellia Therapeutics has acknowledged the death of the elderly patient hospitalized last week in its Phase III trial of assessing nexiguran ziclumeran (nex-z) in transthyretin amyloidosis with cardiomyopathy (ATTR-CM). The patient, which Intellia described previously […]
Engineers have developed a new design strategy for metal alloy negative electrodes that could significantly improve the performance and durability of next-generation solid-state batteries. The work could help advance the path toward practical, high-performance energy […]
SAN DIEGO, Nov. 7, 2025 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that it will issue financial […]
Healthcare’s most forward-thinking voices come together in a new collaborative series recorded at AI Med 2025. SAN DIEGO, Nov. 7, 2025 /PRNewswire/ — Outcomes Rocket and Censinet today announced the AI Med 2025 Insights Series, […]
DARZALEX Faspro® is co-formulated with Halozyme’s ENHANZE® drug delivery technology SAN DIEGO, Nov. 7, 2025 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced that Johnson & Johnson received U.S. Food and Drug Administration […]
SAN DIEGO, Nov. 6, 2025 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme” or the “Company”), today announced the pricing of $650 million aggregate principal amount of 0% convertible senior notes due 2031 (the “2031 […]
LA JOLLA, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), announces that […]
SAN DIEGO–(BUSINESS WIRE)—- $JANX–Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technologies to its Tumor Activated T Cell Engager (TRACTr), Tumor Activated […]
SAN DIEGO–(BUSINESS WIRE)–Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the third quarter ended September 30, 2025, […]
SAN DIEGO, Nov. 06, 2025 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company or Cidara), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today reported financial results […]
SAN DIEGO–(BUSINESS WIRE)–Physicians and researchers from Ivy Fertility, a globally-recognized network of fertility centers, shared cutting-edge presentations and posters at the 2025 American Society for Reproductive Medicine (ASRM) Conference in San Antonio, Texas last week. […]
Forget velvet ropes and motion sensors. The Stuart Collection makes UC San Diego itself the museum — an open-air gallery of public art where every walk to class can feel like a treasure hunt. Click […]
UC San Diego researchers find that a weeklong mind-body retreat led to rapid changes in brain function and blood biology, boosting resilience, pain relief, and stress recovery—showing how meditation and related practices can quickly impact […]
Phase 1 clinical study data on NRL-1049 shows dose-proportional increase in exposure and favorable safety profile SAN DIEGO, Nov. 6, 2025 /PRNewswire/ — Neurelis, Inc., today announced it will present at the Alliance to Cure […]
Copyright © 2026 Biotech Networks, LLC
